![Kim Kardashian, Jennifer Lopez and Drew Barrymore's favourite body treatment, EMSCULPT® now more affordable than ever before at Thérapie Clinic - Business Cork Kim Kardashian, Jennifer Lopez and Drew Barrymore's favourite body treatment, EMSCULPT® now more affordable than ever before at Thérapie Clinic - Business Cork](https://businesscork.ie/wp-content/uploads/2022/02/models.jpg)
Kim Kardashian, Jennifer Lopez and Drew Barrymore's favourite body treatment, EMSCULPT® now more affordable than ever before at Thérapie Clinic - Business Cork
![Jorge LOPEZ-CASTROMAN | M.D.,Ph.D. | Centre Hospitalier Régional Universitaire de Nîmes, Nîmes | Department of Psychiatry | Research profile Jorge LOPEZ-CASTROMAN | M.D.,Ph.D. | Centre Hospitalier Régional Universitaire de Nîmes, Nîmes | Department of Psychiatry | Research profile](https://i1.rgstatic.net/ii/profile.image/892650358071298-1589835838580_Q512/Jorge-Lopez-Castroman.jpg)
Jorge LOPEZ-CASTROMAN | M.D.,Ph.D. | Centre Hospitalier Régional Universitaire de Nîmes, Nîmes | Department of Psychiatry | Research profile
![Evaluation metrics obtained with LSTM-LSTM-CRF with EMA model for each... | Download Scientific Diagram Evaluation metrics obtained with LSTM-LSTM-CRF with EMA model for each... | Download Scientific Diagram](https://www.researchgate.net/publication/340635832/figure/tbl2/AS:880442987257871@1586925374439/Evaluation-metrics-obtained-with-LSTM-LSTM-CRF-with-EMA-model-for-each-named-entity.png)
Evaluation metrics obtained with LSTM-LSTM-CRF with EMA model for each... | Download Scientific Diagram
![Frontiers | Ecological Momentary Assessment Is a Feasible and Valid Methodological Tool to Measure Older Adults' Physical Activity and Sedentary Behavior Frontiers | Ecological Momentary Assessment Is a Feasible and Valid Methodological Tool to Measure Older Adults' Physical Activity and Sedentary Behavior](https://www.frontiersin.org/files/MyHome%20Article%20Library/343030/343030_Thumb_400.jpg)
Frontiers | Ecological Momentary Assessment Is a Feasible and Valid Methodological Tool to Measure Older Adults' Physical Activity and Sedentary Behavior
![PDF) Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study PDF) Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study](https://i1.rgstatic.net/publication/364771255_Metabolomics_analysis_of_type_2_diabetes_remission_identifies_12_metabolites_with_predictive_capacity_a_CORDIOPREV_clinical_trial_study/links/635a481f8d4484154a3c06ef/largepreview.png)
PDF) Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
E. Maria Lopez - Director, Nonclinical/CMC Regulatory Writing - Synchrogenix, a Certara company | LinkedIn
![Cancers | Free Full-Text | First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies? Cancers | Free Full-Text | First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?](https://pub.mdpi-res.com/cancers/cancers-13-05548/article_deploy/html/images/cancers-13-05548-g001.png?1636104056)
Cancers | Free Full-Text | First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
E. Maria Lopez - Director, Nonclinical/CMC Regulatory Writing - Synchrogenix, a Certara company | LinkedIn
Maria Lopez-Mendez MBA, CPRP - Director of Recruiting - University of Missouri-Columbia, School of Medicine | LinkedIn
![Cancers | Free Full-Text | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? Cancers | Free Full-Text | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?](https://pub.mdpi-res.com/cancers/cancers-13-05204/article_deploy/html/images/cancers-13-05204-g001.png?1634563076)
Cancers | Free Full-Text | Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
![Cancers | Free Full-Text | Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges Cancers | Free Full-Text | Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges](https://pub.mdpi-res.com/cancers/cancers-13-04582/article_deploy/html/images/cancers-13-04582-g001.png?1631961223)